Body Recomposition Stack (Tesamorelin + CJC/Ipamorelin + MOTS-c + BPC-157)

There's no single "recomp stack" — it's a category of bundle sold under names like the "fat loss trifecta," and the exact line-up varies by clinic. The common backbone is a growth-hormone pairing: tesamorelin and/or CJC-1295 with ipamorelin, all of which nudge the pituitary to release more of your own growth hormone. To that, sellers bolt on a "metabolic" peptide like MOTS-c (marketed for mitochondrial energy and insulin sensitivity), a "repair" peptide like BPC-157 to keep tendons happy under training, and sometimes a dedicated fat-loss agent such as AOD-9604 or even a GLP-1-class drug like retatrutide. The logic is divide-and-conquer: each peptide is assigned a job in the cut.

The sales story is "recomposition" — the holy grail of losing fat and gaining muscle at the same time. Clinics frame the GH peptides as preserving lean mass and reducing visceral fat, MOTS-c as a metabolic "flexibility" booster for when you feel flat on a cut, and BPC-157 as injury insurance so you can keep training hard. It's marketed as a synergistic system where the parts add up to more than the sum: appetite and fat handled by one lever, muscle and recovery by another. The combo is popular partly because the GH peptides are relatively cheap and widely available through wellness clinics. Worth noting: no clinical trial has ever tested the combined "stack" — the synergy is a marketing claim, not a finding.

Stacking doesn't average out the evidence — it stacks the unknowns. Tesamorelin (Grade A) is the one genuinely well-evidenced member, but its human data is for reducing visceral fat in HIV-associated lipodystrophy, not for "recomp" in a lean gym-goer. CJC-1295, ipamorelin and AOD-9604 are Grade C: small studies, clinic anecdotes, and in AOD-9604's case a failed Phase II obesity trial. MOTS-c and BPC-157 are Grade D — the body-composition story there is essentially rodent data. Retatrutide (Grade B) is the only member with serious modern fat-loss trials, and it's a different beast entirely from the GH peptides. So the "system" is one strong drug used off-label, propped up by a scaffolding of thin-to-animal-only evidence. Notice, too, that the people selling the recomp story usually also sell the injections.

None of these is a licensed UK medicine for body recomposition. Tesamorelin is FDA-approved in the US (as Egrifta) for HIV-associated lipodystrophy but isn't licensed in the UK. CJC-1295, ipamorelin, MOTS-c, BPC-157 and AOD-9604 are sold as unlicensed "research chemicals" with no MHRA check on what's actually in the vial. Retatrutide is investigational. Buying a multi-peptide "stack" online means trusting an unregulated supplier on purity, dose and identity for several compounds at once.